 |
|
Interaction between sarcopenia and nonalcoholic fatty liver disease
Sae Kyung Joo, Won Kim
Clin Mol Hepatol. 2023;29(Suppl):S68-S78. Published online 2022 Dec 5 DOI: https://doi.org/10.3350/cmh.2022.0358
|
|
Citations to this article as recorded by
 Development and external validation of a machine-learning based model to predict pre-sarcopenia in MASLD population: Results from NHANES 2017–2018
Siwei Yang, Jianan Yu, Qiyang Chen, Xuedong Sun, Yuefeng Hu, Tianhao Su, Jian Li, Long Jin
Annals of Hepatology.2025; 30(2): 101585. CrossRef Appendicular skeletal muscle mass is associated with metabolic dysfunction-associated steatotic liver disease severity in young men: a cross-sectional and longitudinal study
Jaejun Lee, Jinson So, Chang In Han, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Do Seon Song
Hepatology International.2025; 19(1): 181. CrossRef New nomenclature and subclassification of steatotic liver disease and loss of skeletal muscle mass: A longitudinal cohort study
Aryoung Kim, Danbee Kang, Sung Chul Choi, Dong Hyun Sinn, Geum‐Youn Gwak
Hepatology Research.2025; 55(3): 373. CrossRef Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States
Fan Zhang, Longgen Liu, Wenjian Li
Nutrition Journal.2025;[Epub] CrossRef Additive impact of metabolic syndrome and sarcopenia on all-cause and cause-specific mortality: an analysis of NHANES
Meng Zhang, Qing-Yue Zeng, Linli Zhuang
Frontiers in Endocrinology.2025;[Epub] CrossRef Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers
Marwan S Al-Nimer
World Journal of Hepatology.2025;[Epub] CrossRef The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming-Hua Zheng, Takumi Kawaguchi, Wah-Kheong Chan, Diana Payawal, Soek-S
Hepatology International.2025;[Epub] CrossRef Is type 2 diabetes a link between lung function and metabolic dysfunction–associated steatotic liver disease? Insights from population studies and Mendelian randomization
Runmin Cao, Yurun Zhang, Ling Cao, Honghe Jiang
European Journal of Gastroenterology & Hepatology.2025;[Epub] CrossRef Sarcopenia and non-alcoholic fatty liver disease - complex pathogenetic relationships
V. A. Akhmedov, V. S. Marinenko
Experimental and Clinical Gastroenterology.2025; (9): 110. CrossRef Body Composition in Chronic Liver Disease
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
International Journal of Molecular Sciences.2024; 25(2): 964. CrossRef Metabolic-associated fatty liver disease and sarcopenia: A double whammy
Aditya Viswanath, Sherouk Fouda, Cornelius James Fernandez, Joseph M Pappachan
World Journal of Hepatology.2024; 16(2): 152. CrossRef The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations
Ziyan Feng, Fanrong Zhao, Ziyao Wang, Xinyi Tang, Yan Xie, Li Qiu
BMC Gastroenterology.2024;[Epub] CrossRef Systemic immune-inflammation index and all-cause and cause-specific mortality in sarcopenia: a study from National Health and Nutrition Examination Survey 1999-2018
Qing-Yue Zeng, Yu Qin, Yi Shi, Xing-Yu Mu, Shi-Jun Huang, Yu-Hao Yang, Si-Min Liu, Zhen-Mei An, Shuang-Qing Li
Frontiers in Immunology.2024;[Epub] CrossRef Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution?
Francesca Campani, Tancredi Vincenzo Li Cavoli, Umberto Arena, Fabio Marra, Erica Nicola Lynch, Claudia Campani
World Journal of Gastroenterology.2024; 30(17): 2287. CrossRef Machine Learning Reveals Serum Glycopatterns as Potential Biomarkers for the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD)
Xiaocheng Li, Yaqing Xiao, Xinhuan Chen, Yayun Zhu, Haoqi Du, Jian Shu, Hanjie Yu, Xiameng Ren, Fan Zhang, Jing Dang, Chen Zhang, Shi Su, Zheng Li
Journal of Proteome Research.2024; 23(6): 2253. CrossRef Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
Rochelle Wong, Li-Yun Yuan
World Journal of Hepatology.2024; 16(6): 871. CrossRef Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B
Hyunjae Shin, Gyung Sun Lim, Jae Woong Yoon, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yuri Cho, Yun Bin Lee, Eun Ju Cho, Bo Hyun Kim, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Yoon Jun Kim
Journal of Medical Virology.2024;[Epub] CrossRef Sarcopenia-related traits and 10 digestive system disorders: insight from genetic correlation and Mendelian randomization
Tao Yang, Zheng Liu, Mingzhu Xiu, Xiaoman Qing, Sha Liu, Wanmeng Xiao, Muhan Lü
Frontiers in Public Health.2024;[Epub] CrossRef Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, Jatin Behari, Madhulika Tripathi, Brijesh Kumar Singh
Frontiers in Cell and Developmental Biology.2024;[Epub] CrossRef The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
Xiaoyan Li, Jie He, Qiuhua Sun
Clinical Nutrition.2024; 43(9): 2005. CrossRef Bibliometric and visualized analysis of the correlation between sarcopenia and chronic liver diseases from 2000 to 2023
Jiaming Lan, Haozhuo Guo, Jingyu Zou, Jian Xue, Hongbo Ni, Liuchun Wang, Tianhang Ren, Sijie Chai, Haoyang Jiang, Chan Gou, Fan Wang, Shuai Wang, Xiaohe Xu, Yue Wang, Meng Niu
Portal Hypertension & Cirrhosis.2024; 3(3): 139. CrossRef Sarcopenia: A review
Chieh Chen, Da-Ming Liao
Tungs' Medical Journal.2024; 18(Suppl 1): S23. CrossRef The ZJU index is associated with the risk of sarcopenia in American adults aged 20–59: a cross-sectional study
Jia-qi Hao, Shu-yue Hu, Zi-xuan Zhuang, Jia-wan Zhang, Meng-rui Xiong, Rui Wang, Wen Zhuang, Mo-jin Wang
Lipids in Health and Disease.2024;[Epub] CrossRef Sarcopenia as a Risk Factor for Mortality in NAFLD: How Should We Diagnose It?
Catherine Stankevicius, Rachel H. Davis, Dep Huynh, Martine Hatzi, Stephanie Morgillo, Alice S. Day
Journal of Digestive Diseases.2024; 25(11-12): 645. CrossRef GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
Riccardo Nevola, Raffaella Epifani, Simona Imbriani, Giovanni Tortorella, Concetta Aprea, Raffaele Galiero, Luca Rinaldi, Raffaele Marfella, Ferdinando Carlo Sasso
International Journal of Molecular Sciences.2023; 24(2): 1703. CrossRef Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease
Goh Eun Chung, Sohee Oh, Dong-Won Ahn, Su Hwan Kim, Yong Jin Jung, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Ji Bong Jeong
Scientific Reports.2023;[Epub] CrossRef Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease
Ik Hyun Jo, Do Seon Song, U Im Chang, Jin Mo Yang
Scientific Reports.2023;[Epub] CrossRef Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Eileen Laurel Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(2): 371. CrossRef Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Ho Soo Chun, Minjong Lee
Clinical and Molecular Hepatology.2023; 29(2): 377. CrossRef Sarkopenie bei chronischen Lebererkrankungen
Monika Rau
Die Innere Medizin.2023; 64(6): 525. CrossRef MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study
Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(9): 1598. CrossRef Lean nonalcoholic fatty liver disease and sarcopenia
Milian Chen, Ying Cao, Guang Ji, Li Zhang
Frontiers in Endocrinology.2023;[Epub] CrossRef Aerobic and Resistance Exercise: Synergistic Influence for Nonalcoholic Fatty Liver Disease
Ho Soo Chun
Gut and Liver.2023; 17(4): 485. CrossRef Waiting for the changes after the adoption of steatotic liver disease
Eileen L. Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(4): 844. CrossRef Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
Eugene Han, Yong-ho Lee
Clinical and Molecular Hepatology.2023; 29(4): 980. CrossRef Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe
Clinical and Molecular Hepatology.2023; 29(4): 987. CrossRef What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?
Katarzyna Ferenc, Sara Jarmakiewicz-Czaja, Rafał Filip
Life.2023; 14(1): 37. CrossRef
|